Our Resource Centre contains an online library dedicated to MiP as well as our publications.
The performance of a rapid diagnostic test in detecting malaria infection in pregnant women and the impact of missed infections.
Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.
Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya
Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy
Declining Malaria Transmission and Pregnancy Outcomes
in Southern Mozambique
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin – piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
Quality assurance of drugs used in clinical trials: proposal for adapting guidelines
Plasmodium falciparum dihydropteroate synthetase-A581G mutation reduces effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women
International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project
New report by the MiP Consortium on the Contribution of Malaria Control to Maternal and Newborn Health launched at the annual High-Level Segment of the United Nations Economic and Social Council (ECOSOC) in New York on 10 July.
For older research items, please visit the
For older news items, please visit the
Copyright © Malaria in Pregnancy Consortium 2011 - Disclaimer - Site Map